Incidence of New-Onset HTN Higher for COVID-19 vs Influenza Patients
For patients with COVID-19, the incidence of new-onset persistent hypertension is higher than among those with influenza.
Stay updated with breaking news from Timq Duong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For patients with COVID-19, the incidence of new-onset persistent hypertension is higher than among those with influenza.
Despite study findings showing that 1 in 5 patients hospitalized for COVID-19 developed persistent high blood pressure, many had underlying risk factors.
Hospitalized and nonhospitalized patients with COVID-19 more likely to develop persistent HTN than those with influenza.
COVID-19 is more likely to trigger persistent high blood pressure than influenza, according to new research from the American Heart Association. About 21% of people hospitalized by the coronavirus develop hypertension within 6 months, compared to 16% of those hospitalized by the flu, the study showed. A similar relationship occurred among those who fell ill without needing hospitalization.
COVID-19 survivors are twice as likely to develop hypertension compared to those with the flu, according to a study.